Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung Resection
A Randomized Pilot Study of ICNB With Ropivacaine Versus ICNB With Cryotherapy for Postoperative Pain Management After RATS Anatomical Resection for Lung Cancer.
1 other identifier
observational
6
1 country
1
Brief Summary
This is a pilot study in which a total of 6 people will participate. This study aims to optimize the postoperative pain management of an anatomically minimally invasive lung resection (RATS) by comparing 2 pain-relieving techniques. As standard, an intercostal block is placed at the end of the procedure by injecting a local anesthetic at the site where the patient will be operated on. This study compares the previous method with the use of cryotherapy as an intercostal block. This technique uses cryo probes and blocks postoperative pain for 1-3 months. By comparing both techniques, it is examined whether cryotherapy requires less pain medication and is therefore more effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2025
CompletedStudy Start
First participant enrolled
March 25, 2025
CompletedFirst Posted
Study publicly available on registry
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
May 6, 2026
April 1, 2026
1.4 years
March 21, 2025
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The NRS pain score
The NRS score will be used to measure pain scores and this will be the primary outcome of the study.
Baseline, post-operative (day 0) in the recoveryward when the patient is awake and after 6 hours. Day 1-2-3 the NRS wil be measured in the morning, afternoon and evening. During the Follow-up visits: 2 weeks and 12 weeks after surgery
Secondary Outcomes (8)
QoR-15 questionnaire
Measured at baseline, post-operative after surgery day 0, day 1, day 2 day 3 and day 4 during hospitalisation. At Folluw-up visit after 2 weeks and after 12 weeks
Lenght of stay
From date of hospitalization until discharge, estimated time of hospitalisation is 5 days, but we will measure until discharge from the hospital.
Use of pain medication
during the postopertieve hospotalization periode, day 0 till day 3
Pain during mobilization
During the postopertieve hospotalization periode, day 0 till day 3
Patient satisfaction
During post-opertieve periode day 0 - day 3.
- +3 more secondary outcomes
Study Arms (2)
R-ICNB
At the end of the procedure, an intercostal block is placed by injecting a local anesthetic into the site of surgery.
C-ICNB
At the end of the surgery single shot cryotherapy will be placed at 6 levels (T3-T8) with the AtriCure"s cryoICE cryosphere cryoablation probes.
Eligibility Criteria
Patients referred for anatomical lung resection (lobectomy or segmentectomy) with the intention of performing it by robotic-assisted thoracoscopic surgery (RATS) are eligible for the trial.
You may qualify if:
- Adult patients of 18 years or older who are able to give informed consent and fill out questionnaires in Dutch.
You may not qualify if:
- Patients who need an anatomic resection of the lung that's larger than one lung lobe, who have CPAM or infections.
- Patients with chronic use (\>3 months) of strong opioids because of co-morbidities -for example, the use of tramadol is allowed.
- If there's a high risk of conversion to a thoracotomy. This will be evaluated by the lung surgeon.
- Patients who have had thoracic surgery in the past.
- Patients with chronic kidney disease stage 4 or 5 (GFR \< 30 mL/min)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Antwerp
Edegem, Antwerp, 2560, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof. J. Hendriks, MD. PhD.
University Hospital, Antwerp
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. J. Hendriks
Study Record Dates
First Submitted
March 21, 2025
First Posted
August 1, 2025
Study Start
March 25, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04